Forward P/S Multiple: SBC Medical Group Holdings Inc. (SBC)

SBC Medical Group Holdings Inc - graphic logo of issuer SBC

Expanding demand for minimally invasive rejuvenation and the development of franchising are driving growth for SBC Medical Group Holdings Inc (SBC), confirming the projected P/S trend. The level of 3.20 represents the current value of this metric. Business profitability relies on the average check and physician retention, while operational efficiency is maintained through external IT services and logistics outsourcing.

SBC Medical Group - SBC Market Cap to Projected Revenue (period 11/16/2024 - 11/18/2026)

Summary analytical data breakdowns for SBC Medical Group Holdings Inc (SBC)

- company stock exchange capitalization indicators:
Fundamental company analysis:SBC (SBC Medical Group Holdings)
Product sample of SBC Medical Group Inc

The forward P/S ratio measures a company's market value relative to expected revenues, making it possible to distinguish speculative growth from fundamental strength amid rising capital costs. The current value of 3.20, as shown through the expected P/S metric, reflects the premium for the dominance of SBC Medical Group Holdings Inc (SBC) in Japanese aesthetic medicine, where narrow niche specialization requires strict control over revenue forecast accuracy to confirm capital stability.

Who SBC Medical Group Holdings Inc competes with

Forward P/S Multiple HCA (HCA Healthcare, Inc.)|Price to Expected Revenue Ratio THC (Tenet Healthcare)|FMS - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio solventum.com|EHC: Forward P/S Multiple|UHS - Market Cap to Expected Sales Ratio|DVA (DaVita Corp) - Forward P/S Multiple|RDNT: Forward Price to Sales|Forward P/S Multiple OPCH|SGRY (surgerypartners.com) - Forward Price to Sales|Forward P/S Multiple PINC (Premier Inc)|National Vision - Price-to-Projected Revenue Ratio|PGNY - Price-to-Projected Revenue Ratio|ARDT - Forward P/S Multiple|SEM: Forward P/S Multiple|astranahealth.com (ASTH) - Forward P/S Multiple|MD (mednax.com) - Forward P/S Multiple|Forward P/S Multiple usph.com|Forward P/S Multiple PNTG|Market Cap to Expected Sales Ratio Organogenesis Holdings|Forward P/S Multiple NUTX (nutexhealth.com)|Auna SA (AUNA) - Market Cap to Future Revenue Ratio|EOLS - Price-to-Projected Revenue Ratio|Forward Price to Sales CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Forward Price-to-Revenue Multiple|Market Cap to Projected Revenue MDWD|Price-to-Projected Revenue Ratio biote Corp.|Market Cap to Future Revenue Ratio thejoint.com JYNT|Forward P/S Multiple DCGO|Forward Price-to-Revenue Multiple P3 Health PIII|Forward P/S Multiple GANX (Gain Therapeutics Inc.)|Forward P/S Multiple EUDA Health Holdings Limited EUDA|baselmedical.com - Forward P/S Multiple|CLGN: Price-to-Projected Revenue Ratio|Cuprina Holdings (Cayman) Ltd. (CUPR) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Concord Medical|AMS (American Shared Hospital Services Inc) - Forward P/S Multiple|MEDIROM Corp (MRM) - Market Cap to Expected Sales Ratio|Forward P/S Multiple ALBT|Market Cap to Expected Sales Ratio DIH Holding|Forward P/S Multiple XAGE (carmellcosmetics.com)|NIVF: Market Cap to Projected Revenue|ATIP: Forward Price-to-Revenue Multiple|CareMax Medical Group - Price to Expected Revenue Ratio|Kindly MD (KDLY) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue MODV|Price-to-Projected Revenue Ratio Novo Integrated Sciences Corp|Market Cap to Future Revenue Ratio SunLink Health Systems SSY|Price-to-Projected Revenue Ratio IMAC Corp (BACK)